High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine Neoplasms

被引:20
|
作者
Chan, David L. [1 ,2 ,3 ,4 ]
Bernard, Elizabeth J. [1 ]
Schembri, Geoffrey [1 ]
Roach, Paul J. [1 ]
Johnson, Meaghan [1 ]
Pavlakis, Nick [2 ,3 ]
Clarke, Stephen [2 ,3 ]
Bailey, Dale L. [1 ,4 ]
机构
[1] Royal North Shore Hosp, Dept Nucl Med, St Leonards, NSW, Australia
[2] Royal North Shore Hosp, Dept Med Oncol, St Leonards, NSW, Australia
[3] Univ Sydney, Kolling Inst, Bill Walsh Translat Canc Res Lab, Sydney, NSW, Australia
[4] Sydney Vital Translat Canc Res Ctr, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Neuroendocrine neoplasm; Prognosis; Positron emission tomography; F-18-FDG PET/CT; CANCER; PARAMETERS; INDEX;
D O I
10.1159/000504673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction:18-Fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) avidity in neuroendocrine neoplasms (NENs) has been associated with higher-grade disease. F-18-FDG avidity and high SUVmax have been demonstrated to predict poor outcome. Quantitative metrics of F-18-FDG PET, specifically metabolic tumour volume (MTV) and total lesion glycolysis (TLG), have been shown to be prognostic factors in other malignancies, but these have not been investigated to date in NENs.Methods:Patients with NEN undergoing F-18-FDG at Royal North Shore Hospital from 2012 to 2018 were included. Images were analysed with automated segmentation (SUV cut-off of 4) followed by contour verification by a nuclear medicine physician and manual segmentation where required. Variables collected included patient age, histological grade, MTV, TLG, and SUVmax/SUVmean. The primary outcome was overall survival (OS), and the secondary outcome was progression-free survival (PFS). Univariate (UV) and multivariate (MV) analyses were performed for OS and PFS for MTV and TLG separately. For UV analysis, the median MTV and TLG were used to dichotomise the cohort. MTV/TLG for NENs of different histological grade were compared using ANOVA.Results:One hundred and ninety patients were included (median age 63.5, 49% female). Primary site: 42% small bowel, 32% pancreas, 15% other gastrointestinal, 6% lung, 6% other. Grade for gastroenteropancreatic NENs and bronchial NEN: G1/typical carcinoid 37%, G2/atypical carcinoid 40%, G3/large-cell/small-cell neuroendocrine carcinoma 16%, unknown 8%. Median MTV was 4.83 mL (range 0-3,161 mL) and median TLG was 29.22. Patients with high MTV had worse median OS compared to those with low MTV (29.7 months vs. not reached, HR 4.1, 95% CI 2.25-7.49,p< 0.00001). Considered as a continuous variable, MTV predicted for poorer OS on UV (p< 0.00001) and MV (p= 0.003) analyses. Whilst histological grade was significant on both UV and MV, SUVmax was significant on UV (p< 0.00001) but not MV (p= 0.76). Tumours of higher grade had higher MTV (mean MTV - G1: 39.6 mL, G2: 107 mL, G3: 337 mL;p= 0.0001 by ANOVA).Conclusions:Quantitative analysis of F-18-FDG PET in NEN is feasible. High MTV/TLG are predictors of poor prognosis in NEN. Further analyses are underway to investigate a larger cohort of NEN patients.
引用
收藏
页码:950 / 958
页数:9
相关论文
共 50 条
  • [41] The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer
    de Winton, E.
    Heriot, A. G.
    Ng, M.
    Hicks, R. J.
    Hogg, A.
    Milner, A.
    Leong, T.
    Fay, M.
    MacKay, J.
    Drummond, E.
    Ngan, S. Y.
    BRITISH JOURNAL OF CANCER, 2009, 100 (05) : 693 - 700
  • [42] 18-Fluorodeoxyglucose Positron Emission Tomography Does Not Aid in Diagnosis of Pancreatic Ductal Adenocarcinoma
    Matsumoto, Ippei
    Shirakawa, Sachiyo
    Shinzeki, Makoto
    Asari, Sadaki
    Goto, Tadahiro
    Ajiki, Tetsuo
    Fukumoto, Takumi
    Kitajima, Kazuhiko
    Ku, Yonson
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (06) : 712 - 718
  • [43] Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer
    Lee, Jang Eun
    Kim, Sang Woo
    Kim, Jin Su
    Choi, Kyu Yong
    Kang, Won Kyung
    Oh, Seong Taek
    Yoo, Ie Ryung
    Kim, Sung Hoon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (36) : 5072 - 5077
  • [44] Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer
    Jang Eun Lee
    Sang Woo Kim
    Jin Su Kim
    Kyu Yong Choi
    Won Kyung Kang
    Seong Taek Oh
    Ie Ryung Yoo
    Sung Hoon Kim
    World Journal of Gastroenterology, 2012, (36) : 5072 - 5077
  • [45] Incidence and outcome of 18-fluorodeoxyglucose positron emission tomography/computed tomography-detected breast lesions
    LS Haine
    G Rutherford
    CE Ingram
    IJ Jolley
    O Hatsiopoulou
    Breast Cancer Research, 13
  • [46] Relationship Between Exercise and 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of Brain in the Elderly
    Kang, Pengfei
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2020, 10 (08) : 1962 - 1966
  • [47] Incidence and outcome of 18-fluorodeoxyglucose positron emission tomography/computed tomography-detected breast lesions
    Haine, I. S.
    Rutherford, G.
    Ingram, C. F.
    Jolley, I. J.
    Hatsiopoulou, O.
    BREAST CANCER RESEARCH, 2011, 13
  • [48] The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Thyroid Neoplasms
    Lang, Brian Hung-Hin
    Law, Tsz Ting
    ONCOLOGIST, 2011, 16 (04): : 458 - 466
  • [49] 18-fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer
    Laking, G
    Price, P
    THORAX, 2001, 56 : 38 - 44
  • [50] 18-Fluorodeoxyglucose Uptake by Positron Emission Tomography in Extraocular Muscles of Patients with and without Graves' Ophthalmology
    Garcia-Rojas, Leonardo
    Adame-Ocampo, Gloria
    Alexanderson, Erick
    Luis Tovilla-Canales, Jose
    JOURNAL OF OPHTHALMOLOGY, 2013, 2013